Biondo Focus Fund acquires NVIDIA

Bioondo Focus Fund According to the latest documents from the investment company Biondo Focus, the (current portfolio) acquired NVIDIA Corp, BioCryst Pharmaceuticals Inc, Teladoc Health Inc, Moderna Inc, Illumina Inc and sold Vertex Pharmaceuticals within 3 months of the second quarter of 2021. Inc, ServiceNow Inc funds. As of 2021Q2, Biondo Focus Fund owns 21 stocks with a total value of US$78 million. These are the details of the sale.

For details of Biondo Focus Fund stock trading, please visit https://www.gurufocus.com/guru/biondo+focus+fund/current-portfolio/portfolio

These are the top 5 holdings of Biondo Focus Fund

1. Apple Inc (AAPL)-55,000 shares, representing 9.52% of the total investment portfolio.
2. Intuitive Surgical Inc (ISRG)-7,500 shares, accounting for 8.72% of the total investment portfolio.
3. Square Inc (SQ)-27,500 shares, accounting for 8.48% of the total investment portfolio.
4. Bed Bath & Beyond Inc (BBBY)-200,000 shares, accounting for 8.42% of the total investment portfolio.
5. Abiomed Inc (ABMD)-20,000 shares, accounting for 7.89% of the total investment portfolio.

New acquisition: NVIDIA Corp (NVDA)

Bioondo Focus Fund Began to hold NVIDIA Corporation. The purchase price is between US$133.48 and US$200.27, with an estimated average price of US$159.58. The stock is currently trading at approximately $219.410,000. The impact of the acquisition on the investment portfolio was 2.02%. As of June 30, 2021, the holdings are 8,000 shares.

New acquisition: BioCryst Pharmaceuticals Inc (BCRX)

Bioondo Focus Fund Starting to hold BioCryst Pharmaceuticals Inc., the purchase price is between US$9.5 and US$17.24, with an estimated average price of US$13.51. The stock is currently trading at approximately $153,900. The impact of the acquisition on the investment portfolio was 1.8%. As of 2021-06-30, the shareholding is 90,000 shares.

New acquisition: Teladoc Health Inc (TDOC)

Bioondo Focus Fund Begin to hold Teladoc Health Inc. The purchase price is between US$132.71 and US$192.38, with an estimated average price of US$162.47. The stock is currently trading at approximately US$138.67 million. The impact of the acquisition on the investment portfolio was 1.58%. As of June 30, 2021, the shareholding is 7,500 shares.

New acquisition: Moderna Inc (MRNA)

Bioondo Focus Fund The purchase price of Moderna Inc. is between US$129.91 and US$234.98, with an estimated average price of US$177.38. The stock is currently trading at approximately US$440.720000. The impact of the acquisition on the investment portfolio was 1.49%. As of June 30, 2021, the shareholding is 5,000 shares.

Add: Illumina Corporation (ILMN)

Bioondo Focus Fund Increased holdings of Illumina Inc by 21.43%. The purchase price is between US$372.84 and US$481.5, with an estimated average price of US$413.01. The stock is currently trading at approximately $434.59 million. The impact of this purchase on the investment portfolio was 0.9%. As of June 30, 2021, the holdings were 8,500 shares.

Sold Out: Vertex Pharmaceuticals Inc (VRTX)

Bioondo Focus Fund Sold out the shares of Vertex Pharmaceuticals Inc. The price ranges from US$187.49 to US$221.1, with an estimated average price of US$209.31.

Sold Out: ServiceNow Inc (NOW)

Bioondo Focus Fund Sold out of ServiceNow Inc. shares. The price ranges from US$454.4 to US$562.63, with an estimated average price of US$506.28.

This is the complete portfolio of Biondo Focus Fund. Please also check:

1. Biondo Focus Fund’s undervalued stock
2. The top growth company of Biondo Focus Fund, and
3. Biondo Focus Fund’s high-yield stocks
4. Biondo Focus Fund continues to buy stocks